Cerba Research

Your precision medicine partner.

[Cerba Research @CerbaResearch_]

As 2023 draws to a close we would like to wish our colleagues, partners and sponsors a peaceful and joyous time. Happy Holidays from Cerba Research!

[Cerba Research @CerbaResearch_]

At Cerba Research we bring our full collective focus to next-generation drug development: how can we help you deliver the promise of precision medicine for your patients?

Discover more: https://t.co/MCh15hUOZH

#OurCollectiveFocus #CellAndGeneTherapy #Biomarkers

[Cerba Research @CerbaResearch_]

At Cerba Research we understand that well-characterized, high-quality samples are the key to advancing research and health for all. That’s why we are building a virus biobank.

How can our virus biobank further your research?
#OurCollectiveFocus #InfectiousDiseases #Virology

[Cerba Research @CerbaResearch_]

Today’s pharma clinical research requires partnerships with a collective focus on the next generation of healthcare. That’s why at Cerba Research our speciality lab solutions can be integrated into your current supplier agreements to give you the flexibility and agility you need.

[Cerba Research @CerbaResearch_]

In this week’s #ImageOfTheWeek, we’re diving deeper into a human epidermal growth factor receptor 2 expression in gastric cancer.

The HercepTest mAB pharmDx is indicated as an aid in the assessment of gastric cancer patients to determine the most appropriate therapy.

#IHC

[Cerba Research @CerbaResearch_]

Get the best of both worlds when you partner with Cerba Research: a central and speciality lab providing full-service solutions from routine to speciality testing, including assay development, logistics and kit building.

Discover it here: https://t.co/5j5KZvykQo

[Cerba Research @CerbaResearch_]

Every research sample is a potential patient saved.

We understand that the future of clinical research relies on safeguarding the integrity of your samples.

Learn more: https://t.co/5h2odDUgQS

#ClinicalResearch #OurCollectiveFocus

[Cerba Research @CerbaResearch_]

What did you take away from this year’s World Vaccine Congress in Barcelona?

Want to find out more about how our virology expertise can accelerate your response to emerging disease? Get in touch today: https://t.co/jdMyqlFzJT

#WorldVaccineCongress #Virology #OurCollectiveFocus

[Cerba Research @CerbaResearch_]

Did you attend Marc Van Pruijssen's presentation today on "An agile approach to PBMC collection in vaccine trials" at the World Vaccine Congress? Don't worry if you couldn't, you can still meet up with our team at booth 60 today!

#ClinicalTrials #DrugDevelopment #PBMC

[Cerba Research @CerbaResearch_]

Attending this year’s edition of The World Vaccine Congress in Barcelona? Our team is ready to welcome you!

Discover how we are setting the standards to protect the world against infectious disease!

#WorldVaccineCongress #Virology #OurCollectiveFocus #WVCEU

[Cerba Research @CerbaResearch_]

What if you could identify a better pathway to finding the right treatment for the right patient at the right time?

Discover our oncology services: https://t.co/E7QA8hxc9J

#OurCollectiveFocus #Oncology

[Cerba Research @CerbaResearch_]

Since 1992, Cerba Research have built expertise in the field of genetic testing. Thanks to this experience, we are able to collaborate with the life science community to provide the most suitable genomic service and enhance the power of your genetic material.

[Cerba Research @CerbaResearch_]

At Cerba Research we’re looking to the future – for our clients, our people and patients.

It’s time for a renewed focus.

Keep following to find out more.

#OurCollectiveFocus

[Cerba Research @CerbaResearch_]

At Cerba Research, we are looking to the future; a future where together we can change the face of precision and predictive medicine for everyone.

Keep following to find out more.

#OurCollectiveFocus

[Cerba Research @CerbaResearch_]

This week’s #ImageOfTheWeek is a CD163 Expression in Non-Small Cell Lung Cancer. This protocol is used in a phase 1/2 clinical study to detect M2 macrophages in solid tumors.

#TransformingResearch #AdvancingHealth #OncologyTrials #IHC

[Cerba Research @CerbaResearch_]

With 200+ oncology studies in the past 5 years split between solid tumors and hematological malignancies in oncology, Cerba Research has helped pharmaceutical, biotechnology, and biopharmaceutical companies to advance clinical trials.

Discover more: https://t.co/0UPexX4wiq

[Cerba Research @CerbaResearch_]

We are thrilled to present our latest research on decoding the TCR (T-cell receptor) and BCR (B-cell receptor) through immune repertoire sequencing.

Download here:

https://t.co/F4cdgVeNgb

#TransformingReaserch #AdvancingHealth #Genomics #ImmuneRepertoire #TCR

[Cerba Research @CerbaResearch_]

In our newest white paper, Rania Gaspo, BPharm, PhD explores the pivotal role of Next-Generation Sequencing (NGS) panel customization in driving advancements in oncology research!

Discover the newest insights: https://t.co/NyGA9z3PtP

[Cerba Research @CerbaResearch_]

Ready for the Disease Prevention Summit this week? Stop by and meet up with our colleagues Chizoba O. and Ivo Ploemen to discover how we are setting the standards to protect the world against infectious diseases!

Discover more: https://t.co/oIV88UX2S1

[Cerba Research @CerbaResearch_]

In this week's featured #ImageOfTheWeek, we showcase the p16 expression in Uterine Leiomyosarcoma.

This specific protocol has been rigorously validated at the secondary endpoint level.

#TransformingResearch #AdvancingHealth